Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $32.6300 (-0.09%) ($30.0300 - $33.9400) on Wed. May. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.48% (three month average) | RSI | 41 | Latest Price | $32.6300(-0.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.4% a day on average for past five trading days. | Weekly Trend | IOVA declines -5.9% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(46%) ARKG(45%) ARKK(41%) IWO(41%) | Factors Impacting IOVA price | IOVA will decline at least -4.24% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-13%) TBT(-5%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.24% (StdDev 8.48%) | Hourly BBV | 0 () | Intraday Trend | 2.7% | | | |
|
Resistance Level | $34.18 | 5 Day Moving Average | $32.34(0.9%) | 10 Day Moving Average | $33.72(-3.23%) | 20 Day Moving Average | $34.18(-4.53%) | To recent high | -16% | To recent low | 67% | Market Cap | $4.778b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |